Kerizet (Desogestrel)

Desogestrel binds to progesterone receptors in the brain, suppressing the luteinizing hormone surge that triggers ovulation. It also thickens cervical mucus, reducing sperm penetration, and alters the endometrial lining, making implantation of a fertilized egg unlikely.

The specific dosing schedule for Kerizet is determined by the prescribing healthcare professional based on individual patient needs and local guidelines. Patients should follow the prescriber’s instructions and not adjust the dose without medical advice.

Kerizet is classified as pregnancy category X, meaning it must not be used during pregnancy because it can cause harm to the fetus. It is also not recommended while breastfeeding, as desogestrel may be excreted in breast milk and affect the infant.

To order Kerizet, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Kerizet’s active ingredient, desogestrel, is a third‑generation progestin that offers a lower risk of androgenic side effects compared with earlier progestins. It provides comparable contraceptive efficacy to other combined oral contraceptives while often being better tolerated in terms of skin and weight‑related effects.

Kerizet tablets should be stored at ambient temperature, preferably below 25 °C. Keep them in the original packaging, protect from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Kerizet is taken orally, usually once daily at the same time each day as part of a combined oral contraceptive regimen. The tablet is swallowed whole with water and should be taken with or without food as directed by the prescriber.

Serious risks include thromboembolic events such as deep vein thrombosis or pulmonary embolism, especially in women who smoke, are over 35, or have a history of clotting disorders. Rarely, severe allergic reactions can occur, requiring immediate medical attention.

Kerizet should not be used by women who are pregnant, have known or suspected breast cancer, have a history of thromboembolic disease, severe liver disease, or who are smokers over the age of 35. It is also contraindicated in individuals with known hypersensitivity to desogestrel or any tablet excipients.